HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-OCT-16 5TQ5 TITLE DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE TITLE 2 (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TITLE 3 TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 837-1132; COMPND 5 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS KINASE, INFLAMMATION, JAK INHIBITOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.CHRENCIK,P.JONES REVDAT 5 06-MAR-24 5TQ5 1 REMARK REVDAT 4 18-APR-18 5TQ5 1 REMARK REVDAT 3 08-FEB-17 5TQ5 1 JRNL REVDAT 2 18-JAN-17 5TQ5 1 JRNL REVDAT 1 11-JAN-17 5TQ5 0 JRNL AUTH P.JONES,R.I.STORER,Y.A.SABNIS,F.M.WAKENHUT,G.A.WHITLOCK, JRNL AUTH 2 K.S.ENGLAND,T.MUKAIYAMA,C.M.DEHNHARDT,J.W.COE,S.W.KORTUM, JRNL AUTH 3 J.E.CHRENCIK,D.G.BROWN,R.M.JONES,J.R.MURPHY,T.YEOH,P.MORGAN, JRNL AUTH 4 I.KILTY JRNL TITL DESIGN AND SYNTHESIS OF A PAN-JANUS KINASE INHIBITOR JRNL TITL 2 CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND JRNL TITL 3 TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES JRNL TITL 4 OF THE LUNGS AND SKIN. JRNL REF J. MED. CHEM. V. 60 767 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 27983835 JRNL DOI 10.1021/ACS.JMEDCHEM.6B01634 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.31 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 3 NUMBER OF REFLECTIONS : 11921 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.282 REMARK 3 R VALUE (WORKING SET) : 0.279 REMARK 3 FREE R VALUE : 0.332 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 663 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 787 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.75 REMARK 3 BIN R VALUE (WORKING SET) : 0.3810 REMARK 3 BIN FREE R VALUE SET COUNT : 43 REMARK 3 BIN FREE R VALUE : 0.4370 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2370 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 34 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.06000 REMARK 3 B22 (A**2) : -0.02000 REMARK 3 B33 (A**2) : 0.01000 REMARK 3 B12 (A**2) : 0.02000 REMARK 3 B13 (A**2) : 0.03000 REMARK 3 B23 (A**2) : 0.07000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.707 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.361 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.268 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.520 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.852 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.715 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2453 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2316 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3312 ; 1.359 ; 1.958 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5327 ; 1.008 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 290 ; 4.848 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 122 ;37.902 ;24.180 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 443 ;17.364 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;21.703 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 349 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2899 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 578 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1163 ; 1.156 ; 1.698 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1162 ; 1.155 ; 1.697 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1452 ; 2.095 ; 2.541 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1453 ; 2.094 ; 2.542 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1290 ; 0.862 ; 1.766 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1291 ; 0.862 ; 1.766 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1861 ; 1.573 ; 2.607 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2572 ; 2.823 ;11.990 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2573 ; 2.823 ;11.992 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5TQ5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1000224632. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 R CDTE 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11921 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES, PH 7.5, 0.1 M SODIUM REMARK 280 ACETATE, 30% PEG-3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 835 REMARK 465 SER A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 GLY A 1132 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 896 CG CD OE1 OE2 REMARK 470 LYS A 914 NZ REMARK 470 ARG A 922 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 923 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 924 CG OD1 ND2 REMARK 470 LYS A1011 CD CE NZ REMARK 470 LYS A1053 CG CD CE NZ REMARK 470 LYS A1083 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 872 42.06 35.97 REMARK 500 GLN A 885 -69.08 -94.75 REMARK 500 ARG A 975 -9.13 75.62 REMARK 500 ASP A 994 85.15 8.61 REMARK 500 ASP A1068 58.66 -90.68 REMARK 500 TRP A1106 31.67 -93.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7GX A 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TQ8 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ7 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ6 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ4 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ3 RELATED DB: PDB DBREF 5TQ5 A 837 1132 UNP O60674 JAK2_HUMAN 837 1132 SEQADV 5TQ5 GLY A 835 UNP O60674 EXPRESSION TAG SEQADV 5TQ5 SER A 836 UNP O60674 EXPRESSION TAG SEQADV 5TQ5 SER A 1073 UNP O60674 MET 1073 ENGINEERED MUTATION SEQADV 5TQ5 THR A 1076 UNP O60674 PHE 1076 ENGINEERED MUTATION SEQRES 1 A 298 GLY SER GLU ASP ARG ASP PRO THR GLN PHE GLU GLU ARG SEQRES 2 A 298 HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE SEQRES 3 A 298 GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP SEQRES 4 A 298 ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SEQRES 5 A 298 SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE SEQRES 6 A 298 GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS SEQRES 7 A 298 TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU SEQRES 8 A 298 LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG SEQRES 9 A 298 ASP TYR LEU GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE SEQRES 10 A 298 LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET SEQRES 11 A 298 GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG ASP LEU SEQRES 12 A 298 ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL SEQRES 13 A 298 LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN SEQRES 14 A 298 ASP LYS GLU TYR TYR LYS VAL LYS GLU PRO GLY GLU SER SEQRES 15 A 298 PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER SEQRES 16 A 298 LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 298 VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SEQRES 18 A 298 SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP SEQRES 19 A 298 LYS GLN GLY GLN SER ILE VAL THR HIS LEU ILE GLU LEU SEQRES 20 A 298 LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS SEQRES 21 A 298 PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN SEQRES 22 A 298 ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA SEQRES 23 A 298 LEU ARG VAL ASP GLN ILE ARG ASP ASN MET ALA GLY HET 7GX A4000 28 HETNAM 7GX 6-(2-ETHYL-4-HYDROXYPHENYL)-N-(6-METHYLPYRIDIN-3-YL)- HETNAM 2 7GX 1H-INDAZOLE-3-CARBOXAMIDE FORMUL 2 7GX C22 H20 N4 O2 FORMUL 3 HOH *34(H2 O) HELIX 1 AA1 GLU A 845 ARG A 847 5 3 HELIX 2 AA2 THR A 888 LEU A 905 1 18 HELIX 3 AA3 GLY A 921 ASN A 924 5 4 HELIX 4 AA4 SER A 936 LYS A 945 1 10 HELIX 5 AA5 GLU A 946 ILE A 948 5 3 HELIX 6 AA6 ASP A 949 LYS A 970 1 22 HELIX 7 AA7 ALA A 978 ARG A 980 5 3 HELIX 8 AA8 PRO A 1017 TYR A 1021 5 5 HELIX 9 AA9 ALA A 1022 SER A 1029 1 8 HELIX 10 AB1 SER A 1032 THR A 1049 1 18 HELIX 11 AB2 GLU A 1052 LYS A 1055 5 4 HELIX 12 AB3 SER A 1056 GLY A 1066 1 11 HELIX 13 AB4 SER A 1073 ASN A 1084 1 12 HELIX 14 AB5 PRO A 1095 TRP A 1106 1 12 HELIX 15 AB6 ASN A 1109 ARG A 1113 5 5 HELIX 16 AB7 SER A 1115 ALA A 1131 1 17 SHEET 1 AA1 5 LEU A 849 LYS A 857 0 SHEET 2 AA1 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 AA1 5 GLU A 877 LEU A 884 -1 O VAL A 879 N CYS A 866 SHEET 4 AA1 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 AA1 5 TYR A 913 CYS A 917 -1 N GLY A 915 O ILE A 928 SHEET 1 AA2 2 TYR A 972 ILE A 973 0 SHEET 2 AA2 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AA3 2 ILE A 982 ASN A 986 0 SHEET 2 AA3 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 AA4 2 TYR A1008 LYS A1009 0 SHEET 2 AA4 2 LYS A1030 PHE A1031 -1 O PHE A1031 N TYR A1008 SITE 1 AC1 12 ALA A 880 GLU A 898 LEU A 902 MET A 929 SITE 2 AC1 12 GLU A 930 TYR A 931 LEU A 932 PRO A 933 SITE 3 AC1 12 GLY A 935 LEU A 983 ASP A 994 PHE A 995 CRYST1 36.997 45.106 52.807 104.11 110.08 94.73 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027029 0.002236 0.011006 0.00000 SCALE2 0.000000 0.022246 0.006759 0.00000 SCALE3 0.000000 0.000000 0.021072 0.00000